Literature DB >> 3786716

Traction bronchiectasis in end-stage pulmonary fibrosis.

J L Westcott, S R Cole.   

Abstract

Postmortem examination of the lungs of 12 patients with end-stage pulmonary fibrosis revealed the frequent (nine of 12) presence of bronchiectasis. The segmental and subsegmental bronchi were dilated, tortuous, and had a convoluted appearance that resembled a string of pearls. Bronchiectasis was confined to areas of advanced fibrosis. When fibrosis was mild or when it was combined with emphysema, bronchiectasis was absent or mild. Specimen radiographs revealed that bronchiectasis frequently contributed to the radiographic appearance of honeycombing. Retrospective analysis of the plain chest radiographs obtained from five of the patients revealed evidence suggestive of bronchiectasis, but bronchiectasis was difficult to detect unless the surrounding lung was radiopaque. In two living patients with end-stage pulmonary fibrosis, bronchiectasis was much better depicted on computed tomography scans than on plain chest radiographs. In patients with pulmonary fibrosis, the presence of bronchiectasis does not necessarily imply the presence of primary bronchial disease. Rather, bronchiectasis can be a direct result of the fibrotic process.

Entities:  

Mesh:

Year:  1986        PMID: 3786716     DOI: 10.1148/radiology.161.3.3786716

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Comparison of pulmonary thin section CT findings and serum KL-6 levels in patients with sarcoidosis.

Authors:  K Honda; F Okada; Y Ando; H Mori; K Umeki; H Ishii; J Kadota; M Ando; E Miyazaki; T Kumamoto
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

2.  Serial computed tomographic evaluation in desquamative interstitial pneumonia.

Authors:  M Akira; S Yamamoto; H Hara; M Sakatani; E Ueda
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study.

Authors:  Arthur C Theodore; Chi-Hong Tseng; Ning Li; Robert M Elashoff; Donald P Tashkin
Journal:  Chest       Date:  2012-09       Impact factor: 9.410

4.  Pulmonary gangrene and the air crescent sign.

Authors:  J M Reich
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

5.  Traction bronchiectasis in cryptogenic fibrosing alveolitis: associated computed tomographic features and physiological significance.

Authors:  Sujal R Desai; Athol U Wells; Michael B Rubens; Roland M du Bois; David M Hansell
Journal:  Eur Radiol       Date:  2002-12-19       Impact factor: 5.315

Review 6.  Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.

Authors:  Diego J Maselli; Bravein Amalakuhan; Holly Keyt; Alejandro A Diaz
Journal:  Int J Clin Pract       Date:  2017-02       Impact factor: 2.503

7.  Radiological and pulmonary function outcomes of children with SARS.

Authors:  A M Li; H K So; W Chu; P C Ng; K L Hon; W K Chiu; C W Leung; Y S Yau; W K Mo; T F Fok
Journal:  Pediatr Pulmonol       Date:  2004-12

8.  H1N1 pneumonia: our experience in 50 patients with a severe clinical course of novel swine-origin influenza A (H1N1) virus (S-OIV).

Authors:  T Valente; F Lassandro; M Marino; F Squillante; M Aliperta; R Muto
Journal:  Radiol Med       Date:  2011-10-21       Impact factor: 3.469

Review 9.  Beyond bronchitis: a review of the congenital and acquired abnormalities of the bronchus.

Authors:  Thomas Marini; Susan K Hobbs; Abhishek Chaturvedi; Kathrine Kaproth-Joslin
Journal:  Insights Imaging       Date:  2016-12-13

10.  Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports.

Authors:  Satoshi Okamori; Takanori Asakura; Keita Masuzawa; Hiroyuki Yasuda; Hirofumi Kamata; Makoto Ishii; Tomoko Betsuyaku
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.